Cannasouth Limited (NZX:CBD) announces the appointment of David Petterson as a director of the following subsidiaries:
1. Cannasouth Cultivation Limited;
2. Eqalis Group New Zealand Limited;
3. Eqalis Innovations Limited;
4. Eqalis Pharmaceuticals Limited; and
5. Restoreme Clinic Limited,
and that Mark Lucas and Colin Foster are no longer directors of those companies.
The above changes are effective from 16 August 2024.
-ENDS-
For further information visit www.cannasouth.co.nz or contact:
Garry Whimp Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 587 230
Ben Francis
Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 042 6991
New Zealand shares ended firmer after Infratil and Spark posted gains.
The case was a first for New Zealand courts, FMA says.
Budget funding for new inflation-reporting tech is a giant leap forward, agency says.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details